LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Hatch Medical Issued Two Patents
Spine

Hatch Medical Issued Two Patents

March 25, 2013 1 min read Premium comments

Advertisement

Hatch Medical Issued Two Patents
Courtesy: Hatch Medical
Secondary

Hatch Medical, a medical device incubator and technology brokerage firm, has received two U.S. patents for a unique and interesting percutaneous spinal stabilization system. The firm had entered into a joint venture with physician inventor J. Kevin McGraw, M.D., to develop and market his “microinvasive” spinal stabilization technology to spine surgeons everywhere.

McGraw’s invention is a new, minimally invasive way to stabilize adjacent vertebrae while also preserving patient mobility. The system relies on an image-guided, 10 gauge percutaneous placement of a series of curved stabilization rods which cross-link the adjacent vertebrae.

“We believe our percutaneous system will provide an effective alternative to treat discogenic back pain, ” said McGraw. “Our system permits a fast, efficacious and cost effective option to stabilize and support the targeted region.”

According to company officials, percutaneous, minimally invasive spinal procedures help physicians to significantly improve patient outcomes and cost by reducing recovery time and postoperative pain. “The issuance of these patents is a supportive step in the evolution of next generation spinal stabilization devices, ” said Steven Hvozda, of Hatch Medical. “We’re excited to move aggressively forward with the implementation of our market strategy, ” he said.

The physician founded company was started 13 years ago as an incubator and broker of medical device technologies to help clients sell, license or distribute their medical device assets.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy